Justice Department Intensifies Antitrust Investigation of Nvidia
Nvidia Antitrust Investigations Intensify – The U.S. Justice Department (DOJ) has escalated its investigation into Nvidia Corp. by issuing subpoenas to the chipmaker and other
Home
Page 26
US Stocks Take a Hit as September Begins
Tech Stocks Lead the Decline – US stocks fell sharply on Tuesday, marking the start of September, a month known for its historical challenges in
US Gasoline Futures Plunge as Summer Driving Season Ends
US Gasoline Futures Drop to 2021 Lows US gasoline futures fell sharply on Tuesday, marking a significant decline. Prices dropped nearly 6%, reaching their lowest
Costco Increases Membership Fees for the First Time in Six Years
Costco’s Membership Fees Rise: What It Means for Shoppers and the Retail Giant -Costco Wholesale Corporation (COST) has announced an increase in its annual membership
Recursion Pharmaceuticals Plunges 15% After Mixed Phase 2 Trial Results for CCM Treatment
Recursion Pharmaceuticals Faces Market Backlash After Phase 2 Trial Results Update Shares of Recursion Pharmaceuticals (NASDAQ: RXRX) fell sharply on Tuesday, after the company released
Liberty Latin America Faces Mixed Institutional Moves Amid Changing Stock Ratings
Institutional Investors Adjust Liberty Latin America Holdings Ingalls & Snyder LLC reduced its stake in Liberty Latin America Ltd. (NASDAQ: LILA) by 42.1% in the
Iris Energy Defies Doubts with Record Revenue and Aggressive Expansion Plans
Iris Energy Overcomes Doubts with Record Revenue Iris Energy (IREN) recently posted record revenue despite facing a 50% share slump. This drop followed skepticism from
Oil Prices Plummet 4% as Libyan Deal and Weak Demand Weigh on Market
Libyan Deal Sparks Oil Price Drop Oil prices fell more than 4% on Tuesday, hitting their lowest levels in nearly nine months following reports of
IO Biotech: Clinical Trials Progress: Analysts Adjust Ratings Amid New Data
Jefferies Lowers Price Target for IO Biotech Jefferies has maintained its “Buy” rating for IO Biotech (NASDAQ: IOBT) but has reduced its price target from
